News – Page 615
-
NewsHigh Court rules against regulator in pharma transparency case
A High Court judge has concluded that the Health Research Authority acted unlawfully in applying new transparency rules on pharmaceutical companies carrying out clinical trials.
-
NewsCap on clinical negligence costs could save £400m, says Litigation Authority
The health service could save £400m a year if the government changed the law to fix the costs for clinical negligence schemes alongside other measures, the NHS Litigation Authority has said.
-
NewsExecutive Summary: £400m to stop an exodus
Sign up to recieve HSJ’s summary of the day’s must know news and talking points
-
NewsRise in hospitals using ‘risky’ 12 hour shifts for nurses
There has been an increase in the use of 12 hour nursing shifts that potentially put care quality at risk, according a review commissioned by England’s chief nursing officer.
-
NewsExecutive Summary: Sir Ron bows out
Sign up to recieve HSJ’s summary of the day’s essential stories
-
-
NewsCCG property sales 'will fund new care models'
Every clinical commissioning group in England has been directed to evaluate estate within its area to work out how much capital funding can be released by property sales.
-
NewsFirst eight urgent and emergency care vanguards revealed
The first wave of urgent and emergency care vanguard sites has been revealed by NHS England.
-
NewsMapped: The urgent and emergency care vanguard sites
HSJ’s map of the eight sites identified by NHS England as the first urgent and emergency care vanguards.
-
NewsNHS England director: 'Budget constraint' to blame for hepatitis C drug delays
Delays to the introduction of groundbreaking, cost effective hepatitis C drugs have occurred because of ‘budget constraint’, NHS England’s specialised commissioning director has indicated.
-
NewsExecutive Summary: The next wave of new care models
Sign up to recieve HSJ’s summary of the day’s most important stories
-
NewsHSJ Live 24.07.2015: 'Budget constraint' to blame for hepatitis C drug delays, says NHS England director
Delays to introduction of cost effective hepatitis C drugs have occurred because of ‘budget constraint’, NHS England’s specialised commissioning director indicates, plus the rest of today’s news and comment
-
NewsExclusive: Hunt says hospital chief found ‘fit and proper’
The health secretary has said that a hospital chief executive has been assessed as ‘fit and proper’, after regulators considered a series of serious concerns against him.
-
NewsNHS England unveils revamp of cancer drugs fund
The cancer drugs fund should become a ‘managed access’ fund, which would pay for new drugs for a set period before they are approved or rejected by NICE, NHS England has said.
-
NewsBreast cancer drug remains on CDF after ‘significant concessions’
A breast cancer drug will remain on the list of treatments patients can access through the cancer drugs fund after the manufacturer made ‘significant concessions’ on the price.
-
-
NewsHSJ Live 23.07.15: NHS England unveils revamp of cancer drugs fund
CDF should pay for new drugs for set period before they are approved or rejected by NICE, NHS England has said, plus the rest of today’s news and comment
-
NewsDevolution amendment could halt most ambitious local health proposals
Some of local government’s more ambitious proposals for the devolution of responsibility over health could be blown off course by an amendment to the devolution bill passed in the Lords.
-
NewsNHS England review calls for shake-up of children's heart surgery
An NHS England review into congenital heart disease services has called for a major shake-up of how they are provided, proposing a ‘three tier’ model of care.
-
NewsHEE review: Primary care should be favoured for running community nursing
A series of recommendations have been set out by a major review of primary care workforce commissioned by Health Education England.